down arrow

Oculis Holding AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH1242303498
USD
19.70
0.91 (4.84%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

18.9819.84

52 Week

14.0023.08
Valuation
Technical
Day's Volume

CASH

92.59 k

Shareholding (Mar 2025)

FII

1.44%

Held by 8 FIIs

DII

89.34%

Held by 3 DIIs

Promoter

6.54%

How big is Oculis Holding AG?

22-Jun-2025

As of Jun 18, Oculis Holding AG has a market capitalization of 1,193.22 million and reported net sales of 0.00 million with a net profit of -115.95 million for the latest four quarters. Shareholder's funds are 80.97 million and total assets amount to 132.80 million.

As of Jun 18, Oculis Holding AG has a market capitalization of 1,193.22 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 0.00 million for the latest four quarters, while the consolidated net profit for the same period was -115.95 million.<BR><BR>As of Dec 24, the reporting period shows shareholder's funds of 80.97 million and total assets amounting to 132.80 million.

Read More

What does Oculis Holding AG do?

22-Jun-2025

Oculis Holding AG is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $37 million and a market cap of $1.19 billion. Key financial metrics include a negative P/E ratio, a 0% dividend yield, and a return on equity of -43.40%.

Overview: <BR>Oculis Holding AG operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Profit: -37 Million (Quarterly Results - Mar 2025) <BR>Market Cap: USD 1,193.22 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -1.12 <BR>Return on Equity: -43.40% <BR>Price to Book: 6.49<BR><BR>Contact Details: <BR>Registrar Address: Not available.

Read More

Is Oculis Holding AG technically bullish or bearish?

05-Nov-2025

As of October 31, 2025, Oculis Holding AG's trend is neutral with mixed signals, showing a mildly bullish weekly MACD but a mildly bearish monthly MACD, and while it has underperformed the S&P 500 recently, it has outperformed over the past three years.

As of 31 October 2025, the technical trend for Oculis Holding AG has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across different time frames. The weekly MACD is bullish, while the monthly MACD is mildly bearish. Bollinger Bands indicate bullishness on both weekly and monthly charts. However, moving averages are mildly bearish on the daily timeframe, and Dow Theory shows a mildly bearish trend on the weekly basis. <BR><BR>In terms of performance, Oculis has underperformed the S&P 500 over the past week and year, with a return of -10.6% compared to the S&P's 0.71% for the week, and 7.77% versus 19.89% for the year. However, it has outperformed the S&P 500 over the 3-year period with a return of 92.89% compared to 76.66%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 1,043 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.12

stock-summary
Return on Equity

-52.47%

stock-summary
Price to Book

5.80

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-31 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
20.42%
0%
20.42%
6 Months
1.34%
0%
1.34%
1 Year
28.17%
0%
28.17%
2 Years
97.2%
0%
97.2%
3 Years
96.8%
0%
96.8%
4 Years
102.47%
0%
102.47%
5 Years
0%
0%
0.0%

Oculis Holding AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Oculis Holding AG technically bullish or bearish?

As of 31 October 2025, the technical trend for Oculis Holding AG has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across different time frames. The weekly MACD is bullish, while the monthly MACD is mildly bearish. Bollinger Bands indicate bullishness on both weekly and monthly charts. However, moving averages are mildly bearish on the daily timeframe, and Dow Theory shows a mildly bearish trend on the weekly basis. In terms of performance, Oculis has underperformed the S&P 500 over the past week and year, with a return of -10.6% compared to the S&P's 0.71% for the week, and 7.77% versus 19.89% for the year. However, it has outperformed the S&P 500 over the 3-year period with a return of 92.89% compared to 76.66%....

Read More

Is Oculis Holding AG technically bullish or bearish?

As of 31 October 2025, the technical trend for Oculis Holding AG has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed signals across different indicators. The weekly MACD is bullish, while the monthly MACD is mildly bearish. The Bollinger Bands indicate a mildly bullish stance on the weekly and bullish on the monthly. However, the daily moving averages and the weekly OBV are mildly bearish. In terms of performance, Oculis has underperformed the S&P 500 over the past week with a return of -9.27% compared to the S&P's 0.71%, but has outperformed over the past month with a return of 10.8% versus 1.92%. Year-to-date, the stock has returned 13.41%, lagging behind the S&P 500's 16.30%....

Read More

Is Oculis Holding AG technically bullish or bearish?

As of 31 October 2025, the technical trend for Oculis Holding AG has changed from mildly bullish to sideways. The current technical stance is neutral, with mixed signals across different indicators. The weekly MACD is bullish, while the monthly MACD is mildly bearish. Bollinger Bands show a mildly bullish stance weekly and bullish monthly. However, moving averages indicate a mildly bearish trend on the daily timeframe. The KST is bullish on both weekly and monthly, while the Dow Theory presents a mildly bearish weekly view and mildly bullish monthly view. In terms of performance, Oculis has underperformed the S&P 500 over the past week and year, with a return of -9.27% compared to the S&P 500's 0.71% for the week and 12.22% versus 19.89% for the year. However, it has outperformed the S&P 500 over the 3-year period with a return of 93.57% compared to 76.66%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
-163.83%
EBIT to Interest (avg)
-44.53
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.12
Sales to Capital Employed (avg)
0
Tax Ratio
0.19%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
14.16%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
6.55
EV to EBIT
-11.91
EV to EBITDA
-11.98
EV to Capital Employed
-46.54
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-43.40%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 3 Schemes (2.67%)

Foreign Institutions

Held by 8 Foreign Institutions (1.44%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -33.48% vs -60.84% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-25.30",
          "val2": "-25.00",
          "chgp": "-1.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.10",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "1.50",
          "chgp": "-120.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-30.70",
          "val2": "-23.00",
          "chgp": "-33.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 1.42% vs -143.95% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-83.40",
          "val2": "-51.70",
          "chgp": "-61.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "1.50",
          "chgp": "-53.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-17.60",
          "val2": "-42.60",
          "chgp": "58.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-97.40",
          "val2": "-98.80",
          "chgp": "1.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-25.30
-25.00
-1.20%
Interest
0.20
0.10
100.00%
Exceptional Items
-0.30
1.50
-120.00%
Consolidate Net Profit
-30.70
-23.00
-33.48%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -33.48% vs -60.84% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-83.40
-51.70
-61.32%
Interest
0.70
1.50
-53.33%
Exceptional Items
-17.60
-42.60
58.69%
Consolidate Net Profit
-97.40
-98.80
1.42%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 1.42% vs -143.95% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Oculis Holding AG stock-summary
stock-summary
Oculis Holding AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."